ESAB price target lowered to $140 from $148 at Oppenheimer

Oppenheimer analyst Bryan Blair lowered the firm’s price target on ESAB (ESAB) to $140 from $148 and keeps an Outperform rating on the shares. With ESAB down 19% since the start of the Iran war, eventual Middle East rebuild supplementing a powerful set of core growth catalysts, and the close of growth/margin-enhancing Eddyfi on the horizon, the firm sees a compelling buying opportunity on shares. Although Oppenheimer recognizes lingering tactical risks, the firm remains confident in ESAB’s positioning for core EPS inflection during the second half of the year with Eddyfi strengthening the team’s profitable growth trajectory into 2027. And given that setup, it also sees valuation as a legitimate catalyst.